(Q39492199)

12 September 2017

title

Prevention of iron loading in transfusion-dependent thalassaemia (English)

1 reference

12 September 2017

M J Pippard

1

1 reference

12 September 2017

E A Letsky

series ordinal

2

1 reference

12 September 2017

S T Callender

series ordinal

3

1 reference

12 September 2017

D J Weatherall

series ordinal

4

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 June 1978

1 reference

12 September 2017

1 reference

12 September 2017

volume

1

1 reference

12 September 2017

issue

8075

1 reference

12 September 2017

page(s)

1178-1181

1 reference

Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990968-6

7 January 2021

Long-term desferrioxamine therapy in thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990968-6

7 January 2021

Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990968-6

7 January 2021

Continuous subcutaenous administration of deferoxamine in patients with iron overload

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990968-6

7 January 2021

Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990968-6

7 January 2021

Application of Atomic Absorption Spectrophotometry in the Determination of Iron in Urine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990968-6

7 January 2021

The Effect of Ascorbic Acid Deficiency on Desferrioxamine-Induced Urinary Iron Excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990968-6

7 January 2021

Deferoxamine mesylate (Desferal mesylate); A specific iron-chelating agent for treating acute iron intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990968-6

7 January 2021

Clinical and Laboratory Studies on the Action of Desferrioxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990968-6

7 January 2021

10.1016/S0140-6736(78)90968-6

Identifiers

DOI

1 reference

12 September 2017

1 reference